Trials / Completed
CompletedNCT01202084
A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients
A Phase III, Randomized, Open-label, Non-inferiority Study Comparative of Formoterol/Fluticasone Eurofarma 12/250 µg, Foraseq® 12/400 µg and Fluticasone 500 µg in Asthma Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- Eurofarma Laboratorios S.A. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective will be to compare the impact of the study formulations on pulmonary function in persistent asthma carriers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol/Fluticasone | |
| DRUG | Foraseq® | |
| DRUG | Fluticasone |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2010-09-15
- Last updated
- 2015-06-18
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01202084. Inclusion in this directory is not an endorsement.